Real-time enrollment status for this hematopoietic and lymphoid cell neoplasm clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 4:38 AM UTC
| NCT Number | NCT05054413 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphoid Cell Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 10 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | May 26, 2026 (May 26, 2026) |
As of September 2, 2026: Clinical trial NCT05054413 is currently recruiting participants. This clinical trial study for hematopoietic and lymphoid cell neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05054413 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05054413 was last updated May 26, 2026 (May 26, 2026). HelloStudys verifies this status automatically.